Company news: Daiichi Sankyo, Astellas, Takeda

Share this article:
Japanese pharma giants are taking stock of the damage from last Friday's Tohoku Earthquake and tsunami. Tokyo-based Daiichi Sankyo said all its employees were safe and accounted for, though a few had suffered minor injuries. The company said two plants were partly damaged by the earthquake, and sales and marketing activities at several branches in hard-hit areas had been halted. Astellas, also based in Tokyo, said it had confirmed that all of its and its affiliates' employees were safe, but that operations at two manufacturing plants and a chemistry lab had been halted and marketing employees based in devastated regions instructed to remain on standby at home. Osaka-based Takeda announced it would donate 300 million yen and pharmaceutical products to relief efforts.

The pharmaceutical industry ranked well in The National Association of Female Executives' annual list of the top 50 companies for female executives. Among the companies that made the list were Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Lilly, J&J, Merck and Pfizer.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.